至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Development of a novel homogeneous immunoassay using the engineered luminescent enzyme NanoLuc for the quantification of the mycotoxin fumonisin B1

Biosens Bioelectron. 2020-12; 
Tawfiq Alsulami, Nidhi Nath, Rod Flemming, Hui Wang, Wenhui Zhou, Jae-Hyuk Yu
Products/Services Used Details Operation
Monoclonal Antibody Services … cysteine at N terminal (CVTGYRLFEEIL) was purchased from Genscript Co. Monoclonal anti-fumonisin antibody came from Novus Biologicals, and serum-free protein blocking buffer was from ScyTek Laboratories. All aqueous solutions were prepared by using ultrapure water … Get A Quote

摘要

Compared to the traditional heterogeneous assays, a homogeneous immunoassay is a preferred format for its simplicity. By cloning and isolating luminescent proteins from bioluminescent organisms, bioluminescence has been widely used for various biological applications. In this study, we present the development of a homogeneous luminescence immunoassay (FNanoBiT assay) for detection of fumonisin B1 (FB1), based on the binding of two subunits of an engineered luminescent protein (NanoLuc). For the detection of the mycotoxin FB1 in foods, the anti-fumonisin antibody was conjugated to the large subunit of NanoLuc (FLgBiT), and the FB1 was conjugated to the small subunit (FSmBiT). The conjugates were used for the det... More

关键词

Biosensor, FLgBiT, FNanoBiT assay, FSmBiT, Fumonisin, Luminescence